AstraZeneca Stock And 2 UK Shares Trading Below Cash Flow Value

With inflation worries tied to energy prices, rate hike talk in major markets, and uneven growth across regions, many investors are looking for a clearer anchor: cash flow. The Undervalued Stocks Based On Cash Flows screener focuses on companies where projected cash generation, assessed using SWS DCF valuation, sits above what the current share price implies. That gap can indicate potential value for patient investors who want earnings that are supported by underlying cash. In this article, you will see three stocks from this screener that stand out on cash flow valuation grounds.

AstraZeneca (LSE:AZN)

Overview: AstraZeneca is a global biopharmaceutical company based in Cambridge that researches, develops, manufactures, and sells prescription medicines across oncology, cardiovascular, renal and metabolism, respiratory and immunology, vaccines and immune therapies, and rare diseases to healthcare professionals worldwide.

Operations: AstraZeneca generates about $60.4b in revenue, almost entirely from pharmaceuticals.

Market Cap: £192.0b

Investors looking at cash flow backed opportunities may find AstraZeneca interesting because it combines a large, diversified drug portfolio with a late stage pipeline in oncology and other high value areas, plus active use of AI and partnerships to improve R&D productivity. Earnings and margins have been strengthening, and analysts see scope for further improvement, yet the stock trades on a P/E above peers while Simply Wall St’s DCF suggests the current price sits well below estimated fair value, which creates a tension worth unpacking. At the same time, high debt levels, reliance on blockbuster drugs and growing pricing pressure in key markets mean the story is far from risk free.

AstraZeneca’s earnings strength, rich P/E and AI boosted pipeline sit at odds with a share price that Simply Wall St’s model views as below estimated fair value, and the real twist sits in the DCF valuation analysis for AstraZeneca

Foresight Group Holdings (LSE:FSG)

Overview: Foresight Group Holdings is a London based asset manager that runs infrastructure, private equity, venture capital and listed funds, with a clear tilt toward renewable energy, energy transition projects and other real assets across the UK, Europe and Australia. It connects institutional and retail capital with assets such as renewable power, social and digital infrastructure, and smaller private businesses.

Operations: Foresight Group Holdings generates about £114.8m of revenue from Real Assets and £50.1m from Private Equity, with most revenue coming from the United Kingdom and a smaller but meaningful contribution from Australia and Luxembourg.

Market Cap: £531.4m

Foresight Group Holdings stands out on the cash flow screener because it combines strong profitability metrics with a business model tied to long term themes like energy transition and infrastructure funding. Earnings and margins are currently supported by high return on equity and growing fee income. Ongoing share buybacks reduce the share count and concentrate future cash flows for remaining shareholders. At the same time, reliance on performance fees, external funding and policy support for renewables means results can be sensitive to market cycles, regulation and competition. For investors who can handle those trade offs, the mix of real asset exposure, fee based growth and active capital returns makes Foresight a stock worth looking at more closely.

Foresight Group Holdings blends real asset exposure, fee based growth and buybacks, but the real story sits in how those cash flows are priced today and what the DCF valuation analysis for Foresight Group Holdings hints at for the next chapter.

BAE Systems (LSE:BA.)

Overview: BAE Systems is a London headquartered defense and aerospace company that supplies combat vehicles, submarines, fighter jet systems, munitions, electronics, and cyber and intelligence services to governments and defense customers across the US, UK, Europe, the Middle East, Australia, and other international markets.

Operations: BAE Systems generates its revenue primarily from Electronic Systems (£7.5b), Air (£7.4b), Maritime (£6.6b), Platforms & Services (£5.0b), and Cyber & Intelligence (£2.4b), with a small HQ contribution and intra group adjustments.

Market Cap: £53.1b

BAE Systems attracts attention on a cash flow screener because it is tied directly to rising global defense budgets, backed by a £75b order backlog and frequent contract wins in areas like electronic warfare, precision weapons, and space systems. Earnings growth has been steady rather than explosive. Some analysts expect revenue and profit expansion to continue, helped by higher value programs and heavy investment in R&D and capacity. The stock is often assessed as undervalued relative to certain estimates of fair value and analyst targets. It also carries risks related to reliance on large government contracts, supply chain constraints, ESG considerations, and a balance sheet funded entirely by external borrowing. How those cash flows, contracts, and risks all net out is central to evaluating the BAE Systems investment case.

BAE Systems’ rising defense exposure and £75b backlog could be masking a far more interesting story about where future cash flows really land, and the DCF valuation analysis for BAE Systems might be the clue investors are missing.

The three stocks here are just a starting point. The full Undervalued Stocks Based On Cash Flows screener surfaces 38 more companies inside the Undervalued Stocks Based On Cash Flows screener that carry equally compelling cash flow and valuation stories. Use Simply Wall St to identify and analyze the specific catalysts, cash flow traits, and valuation gaps that matter most to you so you can focus on the highest conviction opportunities.

Take Control of Your Investment Journey

If BAE Systems or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Curious About What Else You Might Be Missing?

Fresh ideas can move fast, and potential breakout stocks do not wait around. Before momentum is fully caught and valuations start flying, scan these under the radar lists and act now.

• Spot resilient opportunities that may hold up when others are dropping by scanning the curated 7 resilient stocks with low risk scores built to highlight stability with measurable risk controls.
• Identify potential income-oriented companies by reviewing the hand picked 5 dividend fortresses that focus on higher yielding businesses with balance sheets built to support ongoing payouts.
• Follow the build out of future energy systems by checking the focused 90 nuclear energy infrastructure stocks capturing companies exposed to long term power and infrastructure projects.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com